Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.

Abstract:

:There have been few studies on the specific signaling pathways involved in the transformation of epithelial cells by oncogenic protein tyrosine kinases. Here we investigate the requirement of MAP (MAPK) and phosphatidylinositol 3- (PI3K) kinases in the transformation of rat intestinal epithelial (RIE) cells by oncogenic forms of insulin receptor (gag-IR), insulin-like growth factor-1 receptor (gag-IGFR), and v-Src. MAPK is not significantly activated in cells transformed by gag-IR and gag-IGFR but is activated in v-Src transformed cells. Treatment with PD98059, a MEK inhibitor, at concentrations where MAPK activity was reduced below the basal level showed that MAPK is partially required for the monolayer growth of parental and transformed RIE cells. However, MAPK is not essential for the focus forming ability of the three oncogene-transformed cells. It is also not necessary for the colony forming ability of gag-IR- and gag-IGFR-, but is partially required for v-Src-transformed cells. PI3K is significantly activated in all three oncogene transformed RIE cells. LY294002, a PI3K inhibitor, potently inhibited monolayer growth of all three oncogene-transformed cells. However, at concentrations of LY294002 where activated forms of Akt, a downstream component of the PI3K pathway, were undetectable, colony and focus forming abilities of the v-Src-RIE cells were only slightly affected whereas those of gag-IR/IGFR-RIE cells were greatly inhibited. These results were confirmed using a different pharmacological inhibitor, wortmannin, and a dominant negative form of PI3K, Ap85. Similarly, rapamycin, known to inhibit p70S6 kinase, a downstream component of the PI3K-Akt pathway, also inhibited gag-IR/IGFR-induced, but not v-Src-induced, focus and colony formation. We conclude that the MAPK and PI3K signaling pathways are differentially required for transformation of RIE cells by oncogenic IR and IGFR versus Src and the pattern of requirements is different from that of fibroblast transformation.

journal_name

Oncogene

journal_title

Oncogene

authors

Nguyen KT,Wang WJ,Chan JL,Wang LH

doi

10.1038/sj.onc.1203911

subject

Has Abstract

pub_date

2000-11-09 00:00:00

pages

5385-97

issue

47

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB/cByJ mice to urethane-induction of lung carcinogenesis: differential effects on tumor multiplicity, size and Kras2 mutations.

    abstract::The C3H/HeJ (C3H), A/J and BALB/cByJ (BALB) mouse strains are respectively resistant, sensitive and intermediate regarding the induction of lung tumors by urethane. The phenotypic difference between C3H and A/J is largely determined by the Pas1 (Pulmonary adenoma susceptibility 1) gene on chromosome 6, the A/J allele ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201357

    authors: Karasaki H,Obata M,Ogawa K,Lee GH

    更新日期:1997-10-09 00:00:00

  • ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.

    abstract::Oligodendroglioma is an important type of lower-grade glioma (LGG), which is a slowly progressing brain tumor. Many LGGs eventually transform into a more aggressive or malignant type. Enhanced angiogenesis is a characteristic of malignantly transformed oligodendroglioma (m-oligodendroglioma). However, the pathogenesis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01411-y

    authors: Qi L,Wang ZY,Shao XR,Li M,Chen SN,Liu XQ,Yan S,Zhang B,Zhang XD,Li X,Zhao W,Pan JA,Zhao B,Zhang XD

    更新日期:2020-09-01 00:00:00

  • Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress.

    abstract::Mammalian Stanniocalcin-1 (STC1) is a glycoprotein that has been implicated in various biological processes including angiogenesis. Aberrant STC1 expression has been reported in breast, ovarian and prostate cancers, but the significance of this is not well understood. Here, we report that oxidative stress caused a 40-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.65

    authors: Nguyen A,Chang AC,Reddel RR

    更新日期:2009-05-07 00:00:00

  • In vivo and in vitro effects of v-fos and EJ-Ha-ras oncogene expression in murine epidermal keratinocytes.

    abstract::Primary neonatal Balb/c keratinocyte (NEK) cultures grown, using 3T3 feeder cell support in high calcium, serum supplemented medium, were transfected with EJ-Ha-ras or v-fos DNA sequences and pSV2 neo. Several neo resistant clones were isolated and several established cell lines expressing the transfected gene product...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Appleby MW,Greenfield IM,Crook T,Parkinson EK,Stanley MA

    更新日期:1989-11-01 00:00:00

  • HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kB with other transcription factor families.

    abstract::The trans-activator protein, tax, from the human T leukemia virus type 1 (HTLV-1) trans-activates both viral and cellular genes. It has previously been shown that granulocyte macrophage-colony stimulating factor (GM-CSF) is constitutively expressed in HTLV-1 infected cells and in cells artificially expressing tax. We ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Himes SR,Coles LS,Katsikeros R,Lang RK,Shannon MF

    更新日期:1993-12-01 00:00:00

  • Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.

    abstract::The adenomatous polyposis coli (APC) tumor suppressor gene is mutationally inactivated in both familial and sporadic forms of colorectal cancers. In addition, hypermethylation of CpG islands in the upstream portion of APC, a potential alternative mechanism of tumor suppressor gene inactivation, has been described in c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203704

    authors: Tsuchiya T,Tamura G,Sato K,Endoh Y,Sakata K,Jin Z,Motoyama T,Usuba O,Kimura W,Nishizuka S,Wilson KT,James SP,Yin J,Fleisher AS,Zou T,Silverberg SG,Kong D,Meltzer SJ

    更新日期:2000-07-27 00:00:00

  • DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

    abstract::Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.399

    authors: Fan H,Cui Z,Zhang H,Mani SK,Diab A,Lefrancois L,Fares N,Merle P,Andrisani O

    更新日期:2017-04-27 00:00:00

  • MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.

    abstract::MicroRNAs (miRNAs) make up a novel class of gene regulators; they function as oncogenes or tumor suppressors by targeting tumor-suppressor genes or oncogenes. A recent study that analysed a large number of human cancer cell lines showed that miR-330 is a potential tumor-suppressor gene. However, the function and molec...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.192

    authors: Lee KH,Chen YL,Yeh SD,Hsiao M,Lin JT,Goan YG,Lu PJ

    更新日期:2009-09-24 00:00:00

  • Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.

    abstract::Targeted therapeutics, such as those abrogating hypoxia inducible factor (HIF)/vascular endothelial growth factor signaling, are initially effective against kidney cancer (or renal cell carcinoma, RCC); however, drug resistance frequently occurs via subsequent activation of alternative pathways. Through genome-scale i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.510

    authors: Chen CH,Fong LWR,Yu E,Wu R,Trott JF,Weiss RH

    更新日期:2017-06-22 00:00:00

  • ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT.

    abstract::The crizotinib-resistant ALK(F1174L) mutation arises de novo in neuroblastoma (NB) and is acquired in ALK translocation-driven cancers, lending impetus to the development of novel anaplastic lymphoma kinase (ALK) inhibitors with different modes of action. The diaminopyrimidine TAE684 and its derivative ceritinib (LDK3...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.434

    authors: Debruyne DN,Bhatnagar N,Sharma B,Luther W,Moore NF,Cheung NK,Gray NS,George RE

    更新日期:2016-07-14 00:00:00

  • Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast.

    abstract::Breast carcinoma invasion is associated with prominent alterations in stromal fibroblasts. Carcinoma-associated fibroblasts (CAF) support and promote tumorigenesis, whereas normal mammary fibroblasts (NF) are thought to suppress tumor progression. Little is known about the difference in gene expression between CAF and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.463

    authors: Bauer M,Su G,Casper C,He R,Rehrauer W,Friedl A

    更新日期:2010-03-25 00:00:00

  • A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation.

    abstract::The 5' untranslated region of the proto-oncogene c-myc contains an internal ribosome entry segment (IRES) (Nanbru et al., 1997; Stoneley et al., 1998) and thus c-myc protein synthesis can be initiated by a cap-independent as well as a cap-dependent mechanism (Stoneley et al., 2000). In cell lines derived from patients...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203791

    authors: Chappell SA,LeQuesne JP,Paulin FE,deSchoolmeester ML,Stoneley M,Soutar RL,Ralston SH,Helfrich MH,Willis AE

    更新日期:2000-09-07 00:00:00

  • Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts.

    abstract::Bcl-2 is a key inhibitor of a broad range of apoptotic pathways, yet neither the mechanism of action nor the role of Bcl-2 subcellular localization are well understood. The subcellular localization of Bcl-2 includes the mitochondrial membrane as well as the contiguous membrane of the endoplasmic reticulum and nuclear ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202716

    authors: Lee ST,Hoeflich KP,Wasfy GW,Woodgett JR,Leber B,Andrews DW,Hedley DW,Penn LZ

    更新日期:1999-06-10 00:00:00

  • Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

    abstract::Tuftelin1 (TUFT1), an acidic protein constituent of developing and mineralizing tooth tissues, is regulated by hypoxia and the Hedgehog signaling pathway. We investigated the role of TUFT1 in hepatocellular carcinoma (HCC). qRT-PCR, immunohistochemistry and western blot were employed to evaluate TUFT1 level in HCC. MT...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0505-8

    authors: Dou C,Zhou Z,Xu Q,Liu Z,Zeng Y,Wang Y,Li Q,Wang L,Yang W,Liu Q,Tu K

    更新日期:2019-02-01 00:00:00

  • RECK is a target of Epstein-Barr virus latent membrane protein 1.

    abstract::Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) has been suggested to be involved in tumor metastasis. However, the molecular mechanism of LMP1-induced metastasis is largely unknown. In this study, we investigated the effect of LMP1 on the expression of RECK, a metastasis suppressor gene, in an EBV-negative ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207157

    authors: Liu LT,Peng JP,Chang HC,Hung WC

    更新日期:2003-11-13 00:00:00

  • High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.

    abstract::Pilocytic astrocytomas (PAs, WHO grade I) are the most common brain tumors in the pediatric and adolescent population, accounting for approximately one-fifth of central nervous system tumors. Because few consistent molecular alterations have been identified in PAs compared to higher grade gliomas, we performed array c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.110

    authors: Deshmukh H,Yeh TH,Yu J,Sharma MK,Perry A,Leonard JR,Watson MA,Gutmann DH,Nagarajan R

    更新日期:2008-08-07 00:00:00

  • Molecular and functional characterisation of E2F-5, a new member of the E2F family.

    abstract::The transcription factor DRTF1/E2F is implicated in the control of cellular proliferation due to its interaction with key regulators of cell cycle progression, such as the retinoblastoma tumour suppressor gene product and related pocket proteins, cyclins and cyclin-dependent kinases. DRTF1/E2F DNA binding activity ari...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Buck V,Allen KE,Sørensen T,Bybee A,Hijmans EM,Voorhoeve PM,Bernards R,La Thangue NB

    更新日期:1995-07-06 00:00:00

  • Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells.

    abstract::Constitutive telomerase activity maintains telomere length and confers immortal phenotypes to human cancers. The prevalence of telomerase, rather than a homologous recombination-based mechanism, in telomere length maintenance suggests that telomerase also has auxiliary roles in tumorigenesis. Here, we investigate grow...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.292

    authors: Fleisig HB,Wong JM

    更新日期:2012-02-23 00:00:00

  • Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis.

    abstract::Membrane overexpression of the receptor tyrosine kinase ErbB-2 (MErbB-2) accounts for a clinically aggressive breast cancer (BC) subtype (ErbB-2-positive) with increased incidence of metastases. We and others demonstrated that nuclear ErbB-2 (NErbB-2) also plays a key role in BC and is a poor prognostic factor in ErbB...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.281

    authors: Venturutti L,Romero LV,Urtreger AJ,Chervo MF,Cordo Russo RI,Mercogliano MF,Inurrigarro G,Pereyra MG,Proietti CJ,Izzo F,Díaz Flaqué MC,Sundblad V,Roa JC,Guzmán P,Bal de Kier Joffé ED,Charreau EH,Schillaci R,Elizalde PV

    更新日期:2016-04-28 00:00:00

  • The role of immunoglobulin kappa elements in c-myc activation.

    abstract::Burkitt's lymphoma cells are characterized by chromosomal translocations involving the proto-oncogene c-myc on chromosome 8 and one of the immunoglobulin gene loci on chromosome 2, 14 or 22. The translocated c-myc allele is transcriptionally activated, shows a preferential usage of promoter P1 over P2 (promoter shift)...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hörtnagel K,Mautner J,Strobl LJ,Wolf DA,Christoph B,Geltinger C,Polack A

    更新日期:1995-04-06 00:00:00

  • Snail silencing effectively suppresses tumour growth and invasiveness.

    abstract::The transcription factor Snail has been recently proposed as an important mediator of tumour invasion because of its role in downregulation of E-cadherin and induction of epithelial-mesenchymal transitions (EMT). This behaviour has led to the consideration of Snail as a potential therapeutic target to block tumour pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209997

    authors: Olmeda D,Jordá M,Peinado H,Fabra A,Cano A

    更新日期:2007-03-22 00:00:00

  • Cloning and structural analysis of the human c-kit gene.

    abstract::The recent identification of the mouse White spotting and Steel loci as genes encoding the c-kit receptor and its ligand, respectively, has shed light on the importance of this ligand and receptor in embryogenesis, melanogenesis and hematopoiesis. In order to determine if the c-kit proto-oncogene is involved in human ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Vandenbark GR,deCastro CM,Taylor H,Dew-Knight S,Kaufman RE

    更新日期:1992-07-01 00:00:00

  • Signal transduction pathways regulated by arsenate and arsenite.

    abstract::Arsenate and arsenite activate c-Jun N-terminal kinase (JNK), however, the mechanism by which this occurs is not known. By expressing inhibitory mutant small GTP-binding proteins, p21-activated kinase (PAK) and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinases (MEKKs), we have ident...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203214

    authors: Porter AC,Fanger GR,Vaillancourt RR

    更新日期:1999-12-16 00:00:00

  • Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.

    abstract::Heat shock protein 90 (Hsp90) is a survival signaling chaperone and a cancer chemotherapeutic target. However, we have found that inhibitors of Hsp90 diminished the apoptotic response induced in leukemic cells by the antitumor alkyl-lysophospholipid analog edelfosine, which acts through lipid raft reorganization. Edel...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210816

    authors: Nieto-Miguel T,Gajate C,González-Camacho F,Mollinedo F

    更新日期:2008-03-13 00:00:00

  • Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.

    abstract::beta-catenin activation, and subsequent upregulation of Wnt-signaling, is an important event in the development of certain human and rodent cancers. Recently, mutations in the beta-catenin gene in the region of the serine-threonine glycogen kinase (GSK)-3beta phosphorylation target sites have been identified in hepato...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202858

    authors: Devereux TR,Anna CH,Foley JF,White CM,Sills RC,Barrett JC

    更新日期:1999-08-19 00:00:00

  • SUMOylation inhibits FOXM1 activity and delays mitotic transition.

    abstract::The forkhead box transcription factor FOXM1 is an essential effector of G2/M-phase transition, mitosis and the DNA damage response. As such, it is frequently deregulated during tumorigenesis. Here we report that FOXM1 is dynamically modified by SUMO1 but not by SUMO2/3 at multiple sites. We show that FOXM1 SUMOylation...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.546

    authors: Myatt SS,Kongsema M,Man CW,Kelly DJ,Gomes AR,Khongkow P,Karunarathna U,Zona S,Langer JK,Dunsby CW,Coombes RC,French PM,Brosens JJ,Lam EW

    更新日期:2014-08-21 00:00:00

  • Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.

    abstract::Undifferentiated cells and embryos express high levels of endogenous non-telomerase reverse transcriptase (RT) of retroposon/retroviral origin. We previously found that RT inhibitors modulate cell growth and differentiation in several cell lines. We have now sought to establish whether high levels of RT activity are d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208562

    authors: Sciamanna I,Landriscina M,Pittoggi C,Quirino M,Mearelli C,Beraldi R,Mattei E,Serafino A,Cassano A,Sinibaldi-Vallebona P,Garaci E,Barone C,Spadafora C

    更新日期:2005-06-02 00:00:00

  • Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.

    abstract::The tumor suppressor transcription factor IRF-1 inhibits cell growth. In this report we show that IRF-1 also induces apoptosis of highly transformed and tumorigenic cell lines. This activity of IRF-1 is demonstrated with cell lines expressing HER oncogenes and an activatable IRF-1 fusion protein. Growth of cell lines ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202704

    authors: Kirchhoff S,Hauser H

    更新日期:1999-06-24 00:00:00

  • c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation.

    abstract::The c-Myc oncoprotein is a basic-helix-loop-helix-leucine zipper (b-HLH-LZ) transcription factor involved in regulating cell proliferation and differentiation. We have used retrovirus-mediated gene transfer to investigate the effect of ectopic c-Myc expression on the spontaneous differentiation of primary quail myobla...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: La Rocca SA,Crouch DH,Gillespie DA

    更新日期:1994-12-01 00:00:00

  • The p53 activation and apoptosis induced by DNA damage are reversibly inhibited by salicylate.

    abstract::Treatment of mouse (12)1/CA cells with adriamycin or irradiation with U.V.C. induces p53-dependent transcription of a beta-galactosidase reporter and the endogenous p21/Waf1/Cip1 gene. Despite the induction of Waf1, the cells arrest only transiently in G1 or G2, then resume growth and eventually undergo apoptosis. In ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201104

    authors: Chernov MV,Stark GR

    更新日期:1997-05-29 00:00:00